TY  - CHAP
AU  - M.C. Dechecchi
AU  - E. Nicolis
AU  - P. Mazzi
AU  - M. Paroni
AU  - F. Cioffi
AU  - A. Tamanini
AU  - V. Bezzerri
AU  - M. Tebon
AU  - I. Lampronti
AU  - S. Huang
AU  - L. Wiszniewski
AU  - M.T. Scupoli
AU  - A. Bragonzi
AU  - R. Gambari
AU  - G. Berton
AU  - G. Cabrini
ED  - Dinesh Sriramulu
Y1  - 2012-03-28
PY  - 2012
T1  - Pharmacological Modulators of Sphingolipid Metabolism for the Treatment of Cystic Fibrosis Lung Inflammation
N2  - Living healthy is all one wants, but the genetics behind creation of every human is different. As a curse or human agony, some are born with congenital defects in their menu of the genome. Just one has to live with that! The complexity of cystic fibrosis condition, which is rather a slow-killer, affects various organ systems of the human body complicating further with secondary infections. That's what makes the disease so puzzling for which scientists around the world are trying to understand better and to find a cure. Though they narrowed down to a single target gene, the tentacles of the disease reach many unknown corners of the human body. Decades of scientific research in the field of chronic illnesses like this one surely increased the level of life expectancy. This book is the compilation of interesting chapters contributed by eminent interdisciplinary scientists around the world trying to make the life of cystic fibrosis patients better.
BT  - Cystic Fibrosis
SP  - Ch. 19
UR  - https://doi.org/10.5772/31050
DO  - 10.5772/31050
SN  - 
PB  - IntechOpen
CY  - Rijeka
Y2  - 2024-04-26
ER  -